These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 27513937)

  • 1. Evaluation of Tetrahydrobiopterin Therapy with Large Neutral Amino Acid Supplementation in Phenylketonuria: Effects on Potential Peripheral Biomarkers, Melatonin and Dopamine, for Brain Monoamine Neurotransmitters.
    Yano S; Moseley K; Fu X; Azen C
    PLoS One; 2016; 11(8):e0160892. PubMed ID: 27513937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large neutral amino acid supplementation increases melatonin synthesis in phenylketonuria: a new biomarker.
    Yano S; Moseley K; Azen C
    J Pediatr; 2013 May; 162(5):999-1003. PubMed ID: 23164313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin and dopamine as biomarkers to optimize treatment in phenylketonuria: effects of tryptophan and tyrosine supplementation.
    Yano S; Moseley K; Azen C
    J Pediatr; 2014 Jul; 165(1):184-189.e1. PubMed ID: 24857519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose sapropterin dihydrochloride therapy improves monoamine neurotransmitter turnover in murine phenylketonuria (PKU).
    Winn SR; Scherer T; Thöny B; Harding CO
    Mol Genet Metab; 2016 Jan; 117(1):5-11. PubMed ID: 26653793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
    Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J
    Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic brain modulation with targeted large neutral amino acid supplements in the Pah-enu2 phenylketonuria mouse model.
    van Vliet D; Bruinenberg VM; Mazzola PN; van Faassen MH; de Blaauw P; Pascucci T; Puglisi-Allegra S; Kema IP; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
    Am J Clin Nutr; 2016 Nov; 104(5):1292-1300. PubMed ID: 27655443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice.
    van Vliet D; Bruinenberg VM; Mazzola PN; van Faassen MH; de Blaauw P; Kema IP; Heiner-Fokkema MR; van Anholt RD; van der Zee EA; van Spronsen FJ
    PLoS One; 2015; 10(12):e0143833. PubMed ID: 26624009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of sapropterin on urinary monoamine metabolites in phenylketonuria.
    Douglas TD; Jinnah HA; Bernhard D; Singh RH
    Mol Genet Metab; 2013 Jul; 109(3):243-50. PubMed ID: 23712020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BH4 treatment in BH4-responsive PKU patients: preliminary data on blood prolactin concentrations suggest increased cerebral dopamine concentrations.
    van Vliet D; Anjema K; Jahja R; de Groot MJ; Liemburg GB; Heiner-Fokkema MR; van der Zee EA; Derks TG; Kema IP; van Spronsen FJ
    Mol Genet Metab; 2015 Jan; 114(1):29-33. PubMed ID: 25466353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future role of large neutral amino acids in transport of phenylalanine into the brain.
    Matalon R; Surendran S; Matalon KM; Tyring S; Quast M; Jinga W; Ezell E; Szucs S
    Pediatrics; 2003 Dec; 112(6 Pt 2):1570-4. PubMed ID: 14654667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of patients with phenylketonuria in the US to tetrahydrobiopterin.
    Matalon R; Michals-Matalon K; Koch R; Grady J; Tyring S; Stevens RC
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S17-21. PubMed ID: 16143554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large Neutral Amino Acid Therapy Increases Tyrosine Levels in Adult Patients with Phenylketonuria: A Long-Term Study.
    Burlina AP; Cazzorla C; Massa P; Polo G; Loro C; Gueraldi D; Burlina AB
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31640267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrahydrobiopterin treatment reduces brain L-Phe but only partially improves serotonin in hyperphenylalaninemic ENU1/2 mice.
    Scherer T; Allegri G; Sarkissian CN; Ying M; Grisch-Chan HM; Rassi A; Winn SR; Harding CO; Martinez A; Thöny B
    J Inherit Metab Dis; 2018 Jul; 41(4):709-718. PubMed ID: 29520738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unresponsiveness to tetrahydrobiopterin of phenylalanine hydroxylase deficiency.
    Ponzone A; Porta F; Mussa A; Alluto A; Ferraris S; Spada M
    Metabolism; 2010 May; 59(5):645-52. PubMed ID: 19913839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-year follow-up of B vitamin and Iron status in patients with phenylketonuria provided tetrahydrobiopterin (BH4).
    Brantley KD; Douglas TD; Singh RH
    Orphanet J Rare Dis; 2018 Oct; 13(1):192. PubMed ID: 30373601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sapropterin dihydrochloride for the treatment of hyperphenylalaninemias.
    Blau N
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1207-18. PubMed ID: 23705856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
    Trefz FK; Blau N
    Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study.
    Keil S; Anjema K; van Spronsen FJ; Lambruschini N; Burlina A; Bélanger-Quintana A; Couce ML; Feillet F; Cerone R; Lotz-Havla AS; Muntau AC; Bosch AM; Meli CA; Billette de Villemeur T; Kern I; Riva E; Giovannini M; Damaj L; Leuzzi V; Blau N
    Pediatrics; 2013 Jun; 131(6):e1881-8. PubMed ID: 23690520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of phenylketonuria to tetrahydrobiopterin.
    Michals-Matalon K; Bhatia G; Guttler F; Tyring SK; Matalon R
    J Nutr; 2007 Jun; 137(6 Suppl 1):1564S-1567S; discussion 1573S-1575S. PubMed ID: 17513426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the 48-hour BH4 loading test miss responsive PKU patients?
    van Wegberg AMJ; Evers RAF; van Dam E; de Vries MC; Janssen MCH; Heiner-Fokkema MR; van Spronsen FJ
    Mol Genet Metab; 2020 Mar; 129(3):186-192. PubMed ID: 31924462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.